Original ArticleAn Open-Label Extension Study to Investigate the Long-Term Safety and Tolerability of THC/CBD Oromucosal Spray and Oromucosal THC Spray in Patients With Terminal Cancer-Related Pain Refractory to Strong Opioid Analgesics
Under an Elsevier user license
open archive
Key Words
Cancer
cannabinoid
delta-9-tetrahydrocannabinol
pain
THC/CBD oromucosal spray
Cited by (0)
Copyright © 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.